Hepatitis colestásica aguda secundaria a amoxicilina-ácido clavulánico. Papel del ácido ursodesoxicólico en la colestasis inducida por drogas

Revista Espanola de Enfermedades Digestivas

Volumn 90, Issue 7, 1998, Pages 523-526

  Barrio, J ^a,b   Castiella, A ^a   Lobo, C ^a   Indart, A ^a   Lopez P ^a   Garcia Bengoechea M ^a   Cosme, A ^a   Y Arenas, J I ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Hospital Nuestra Senora de Aranzazu   (Spain)

Author keywords

Amoxicillin; Clavulanic acid and ursodeoxycholic acid; Hepatotoxicity

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; URSODEOXYCHOLIC ACID; AMOXICILLIN; ANTIINFECTIVE AGENT; CHOLAGOGUE; CLAVULANIC ACID; PENICILLIN DERIVATIVE;

AGED; ARTICLE; BILE DUCT OBSTRUCTION; CASE REPORT; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; INFECTION; LIVER NECROSIS; LIVER TOXICITY; MALE; SERODIAGNOSIS; CHEMICALLY INDUCED DISORDER; CHOLESTASIS; TOXIC HEPATITIS;

AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; CLAVULANIC ACID; HEPATITIS, TOXIC; HUMANS; MALE; PENICILLINS; URSODEOXYCHOLIC ACID;

EID: 0032116810     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Westphal JF, Vetter D, Brogard JM. Hepatic side-effects of antibiotics. J Antimicrob Chemother 1994;33:387-401.
2. Reddy KR, Schiff ER. Hepatotoxicity of antimicrobial, antifungal and antiparasitic agents. Med Clin North Am 1995;24:923-36.
3. Reddy KR, Brillant P, Schiff ER. Amoxycillin-clavulanate potassium-associated cholestasis. Gastroenterology 1989;96:1135-41.
4. Ryley NG, Fleming KA, Chapman RWG. Focal destructive cholangiopathy associated with amoxycillin-clavulanic acid (Augmentin). J Hepatol 1995;23:278-82.
5. Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel M, et al. Hepatitis associated with amoxycillin-clavulanic acid recombination report of 15 cases. Gut 1992;33:368-71.
6. Rodriguez M, Sleiman M, Suárez A, Rodrígo L. Hepatitis coiestásica por amoxicilina-ácido clavulánico. Med Clin (Barc) 1991;96:78.
7. Cabelleira E, Massó RM, Aragó JV, Sanchís A. Hepatitis coiestásica por ácido clavulánico. An Med Interna 1992;9:360-1.
8. Del Olmo ME, Panadero FJ, Palacios ML, Carreira J, Panadero E. Hepatitis por amoxicilina más clavulánico. Aten Primaria 1994;14:579-80.
9. Galindo C, Buenestado J, Reñé JM, Piñol MC. Pancreatitis aguda asociada a hepatotoxicidad por amoxicilina-clavulánico Rev Esp Enferm Dig 1995;87:597-600.
10. Caballero Plasencia AM. Valenzuela Barranco M, Martin Ruiz JL, Guilarte López-Mañas J. ?Hepatotoxicidad por amoxicilina, clavulánico o ambos? Gastroenterol Hepatol 1997;20:45-6.
11. Bénichou C. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990;11:272-6.
12. Koek GH, Stricker BH, Blok AP, Schalm SW, Desmet VJ. Flucloxacillin-associated hepatic injury. Liver 1994;14:225-9.
13. Zimmerman HJ, Lewis JH. Drug-induced cholestasis. Med Toxicol 1987;2:112-60.
14. Verhamme M, Ramboer C. Van de Bruaene P, Inderadjaja N. Cholestatic hepatitis due to an amoxycillin-clavulanic acid preparation. J Hepatol 1989;9:260-4.
15. Kosmidis J, Williams JD, Andrews J, Joodall JA, Geddes AM. Amoxycillin-pharmacology, bacteriology and clinical studies. Br J Clin Pract 1972;26:341-6.
16. Stacker BHC, Van de Broek JWG, Keuning J, Eberhardt W, Houben HGJ, Johnson M, et al. Cholestasis hepatitis due to antibacterial combination of amoxycillin and clavulanic acid (Augmentin). Dig Dis Sci 1989;34:1576-80.
17. Ryan J, Dudley FJ. Cholestasis with ticarcillin-potassium clavulanate (Timentin). Med J Aust 1992;156:291.
18. Sweet JM, Jones MP. Intrahepatic cholestasis due to ticarcillin-clavulanate. Am J Gastroenterol 1995;90:675-6.
19. Silvain Ch, Fort E, Levillain P, Labat-Labourdette J, Beauchant M. Granulomatous hepatitis due to combination of amoxycillin and clavulanic acid. Dig Dis Sci 1992;37:150-2.
20. Hautekeete ML, Brenard R, Horsmans Y, Henrion J, Verbist L, Derue G, et al. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. J Hepatol 1995;22:71-7.
21. Hebbard GS, Smith KGC, Gibson PR y Brathal PS. Augmentin-induced jaundice with a fatal outcome. Med J Aust 1992;156:285-6.
22. Piotrowicz A, Polkey M, Wilkinson M. Ursodeoxycholic acid for the treatment of flucloxacillin-associetes cholestasis. J Hepatol 1995;22:119-20.
23. Parés A, Rodés J. Ácido ursodesoxicólico: una alternativa para el tratamiento de la colestasis crónica. Gastroenterol Hepatol 1996;19:58-67.